MediLink's Phase III Triumph: GSK Moves Early as B7-H3 ADC Race Heats Up
May 25, 2026 20:53
CST Updated
May 26, 03:29
MediLink
Antibody-Drug Conjugates Developer
Daiichi - Sankyo
Pharmaceutical Development, Production, Sales, and Consulting Service Provider